Bio-View Ltd (BIOV.TA)
ILA 29.4
(0.0%)
ILA 29.4
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 383 Thousand ILS | -34.75% |
| 2022 | 587 Thousand ILS | -73.12% |
| 2021 | 2.18 Million ILS | 147.06% |
| 2020 | 884 Thousand ILS | -64.99% |
| 2019 | 2.52 Million ILS | 236.19% |
| 2018 | -1.85 Million ILS | -48.08% |
| 2017 | -1.25 Million ILS | -128.22% |
| 2016 | 4.43 Million ILS | 9.12% |
| 2015 | 4.06 Million ILS | 92.88% |
| 2014 | 2.1 Million ILS | 295.91% |
| 2013 | -1.07 Million ILS | -174.62% |
| 2012 | 1.44 Million ILS | -78.07% |
| 2011 | 6.57 Million ILS | 25.59% |
| 2010 | 5.23 Million ILS | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 980.5 Thousand ILS | 0.0% |
| 2024 Q1 | 980.5 Thousand ILS | 282.59% |
| 2023 Q4 | -537 Thousand ILS | 0.0% |
| 2023 FY | 383 Thousand ILS | -34.75% |
| 2023 Q3 | -537 Thousand ILS | -173.71% |
| 2023 Q2 | 728.5 Thousand ILS | 0.0% |
| 2023 Q1 | 728.5 Thousand ILS | 242.01% |
| 2022 Q2 | -414 Thousand ILS | -216.95% |
| 2022 FY | 587 Thousand ILS | -73.12% |
| 2022 Q4 | -513 Thousand ILS | -144.22% |
| 2022 Q3 | 1.16 Million ILS | 380.19% |
| 2022 Q1 | 354 Thousand ILS | 1585.71% |
| 2021 Q2 | 42 Thousand ILS | -95.33% |
| 2021 Q1 | 899 Thousand ILS | 382.7% |
| 2021 FY | 2.18 Million ILS | 147.06% |
| 2021 Q3 | 1.22 Million ILS | 2809.52% |
| 2021 Q4 | 21 Thousand ILS | -98.28% |
| 2020 FY | 884 Thousand ILS | -64.99% |
| 2020 Q4 | -318 Thousand ILS | -118.55% |
| 2020 Q2 | 124 Thousand ILS | 119.5% |
| 2020 Q3 | 1.71 Million ILS | 1282.26% |
| 2020 Q1 | -636 Thousand ILS | -169.28% |
| 2019 Q4 | 918 Thousand ILS | -40.77% |
| 2019 FY | 2.52 Million ILS | 236.19% |
| 2019 Q3 | 1.55 Million ILS | 47.34% |
| 2019 Q1 | -995 Thousand ILS | -576.08% |
| 2019 Q2 | 1.05 Million ILS | 205.73% |
| 2018 Q3 | -1.03 Million ILS | -330.65% |
| 2018 FY | -1.85 Million ILS | -48.08% |
| 2018 Q1 | -1.47 Million ILS | -499.73% |
| 2018 Q2 | 447 Thousand ILS | 130.22% |
| 2018 Q4 | 209 Thousand ILS | 120.27% |
| 2017 Q2 | -996 Thousand ILS | 0.0% |
| 2017 FY | -1.25 Million ILS | -128.22% |
| 2017 Q4 | 370 Thousand ILS | 0.0% |
| 2017 Q3 | 370 Thousand ILS | 137.15% |
| 2017 Q1 | -996 Thousand ILS | -135.48% |
| 2016 Q1 | 216 Thousand ILS | -90.39% |
| 2016 FY | 4.43 Million ILS | 9.12% |
| 2016 Q4 | 2.8 Million ILS | 664.85% |
| 2016 Q3 | 367 Thousand ILS | -64.95% |
| 2016 Q2 | 1.04 Million ILS | 384.72% |
| 2015 Q2 | 1.02 Million ILS | 5.44% |
| 2015 Q1 | 974 Thousand ILS | -12.09% |
| 2015 Q3 | -182 Thousand ILS | -117.72% |
| 2015 FY | 4.06 Million ILS | 92.88% |
| 2015 Q4 | 2.24 Million ILS | 1334.62% |
| 2014 Q2 | 821 Thousand ILS | 11628.57% |
| 2014 FY | 2.1 Million ILS | 295.91% |
| 2014 Q4 | 1.1 Million ILS | 544.19% |
| 2014 Q1 | 7000.00 ILS | -94.89% |
| 2014 Q3 | 172 Thousand ILS | -79.05% |
| 2013 Q1 | -640 Thousand ILS | 0.0% |
| 2013 Q2 | -739 Thousand ILS | -15.47% |
| 2013 Q3 | 166 Thousand ILS | 122.46% |
| 2013 Q4 | 137 Thousand ILS | -17.47% |
| 2013 FY | -1.07 Million ILS | -174.62% |
| 2012 FY | 1.44 Million ILS | -78.07% |
| 2011 FY | 6.57 Million ILS | 25.59% |
| 2010 FY | 5.23 Million ILS | 0.0% |
| Name | Net Income | Net Income Difference |
|---|